Eli Lilly and Chugai jointly ventured by 50:50 in Japan.

Eli Lilly and chugai Pharmaceutical announced plans to set up a 50: 50 joint venture in Japan called the Chugai Lilly Clinical Research Company. Based in Tokyo, the JV will manage the development of selected Lilly products targeted for the Japanese market and in return, Chugai will receive certain co-promotion and co-marketing rights to those products. The new entity will be capitalized at 200 ...